DNA X, Inc. (SONM)
DNA X, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
DNA X, Inc. (SONM) is a Communication Equipment company based in US with a market capitalization of $4.5M. Free cash flow was negative at -$23.5M. This page tracks SONM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 160 employees · IPO May 10, 2019
Valuation
Valuation & price
$4.48 · as of May 23, 2026 · -73.4% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.5M
Market cap
—
Revenue growth (YoY)
17.0%
Gross margin
-$23.5M
Free cash flow (USD)
$3.9M
Net debt
-84.7%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Technology
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2021 → 2024
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 20, 2026 (EPS $-3.11)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventSecurities Purchase AgreementJul 2, 2026Filing
- 8-K eventAgreement TerminationJun 4, 2026Filing
- 8-K eventSecurities Purchase AgreementMay 27, 2026Filing
- 8-K eventFinancial Results ReleasedMay 20, 2026Filing
- Quarterly report10-Q FiledMay 20, 2026Filing
- 8-K eventAccounting Firm ChangeApr 30, 2026Filing
- Annual report10-K FiledApr 30, 2026Filing
- 8-K eventFinancial Results ReportedApr 15, 2026Filing
- Annual report10-K FiledApr 15, 2026Filing
Questions
Frequently asked questions
What is DNA X, Inc.'s market cap?
DNA X, Inc. (SONM) has a market capitalization of $4.5M.
What is SONM's P/E ratio?
A meaningful P/E ratio is not available for SONM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did DNA X, Inc. last report earnings?
SONM last reported earnings on May 20, 2026; the next date is not yet scheduled.
Are insiders buying SONM stock?
SEC Form 4 filings show no open-market insider buys at DNA X, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Communication Equipment
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.